RFK Jr’s vaccine panel recommends new RSV treatment for infants
by Jessica Glenza from Science | The Guardian on (#6Y8HD)
Move comes after health secretary replaced advisory board with ideological allies and several vaccine skeptics
Robert F Kennedy Jr's reconstituted vaccine advisory panel recommended a new treatment to prevent respiratory syncytial virus (RSV) in infants.
The treatment, a new monoclonal antibody called clesrovimab, which will be sold under the brand name Enflonsia by Merck, was recommended by the powerful committee after being approved by the Food and Drug Administration (FDA) roughly two weeks ago.
Continue reading...